Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer

NCT02911350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Hormone Suppressors
DRUG: Paclitaxel
RADIATION: Radiation Therapy

Sponsor

NYU Langone Health